Barclays
SAVAW

Barclays’s Cassava Sciences, Inc. Warrant SAVAW Stock Holding History

Barclays’s Portfolio SAVAW Stock Details SAVAW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-40,987
Closed -$165K – 5427
2024
Q1 		$165K Buy
+40,987
New +$245K ﹤0.01% 4217

Other funds holding SAVAW

Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
MG
Mather Group Chicago, Illinois $11.5B AUM 18.82% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Barclays's SAVAW Position: Q2 2024 in Review

Barclays sold out of Cassava Sciences, Inc. Warrant (SAVAW) in Q2 2024, closing a stake of 40,987 shares — an estimated $165K sold.

Barclays first reported a position in SAVAW in Q1 2024 and held it in 1 quarter. The position peaked at $165K in Q1 2024. 3 funds tracked by Wall St. Rank hold SAVAW as of Q2 2024.

  • Barclays reported no remaining Cassava Sciences, Inc. Warrant position as of Q2 2024 after selling out during the quarter.
  • Barclays sold 40,987 Cassava Sciences, Inc. Warrant shares in Q2 2024, an estimated $165K.
  • Barclays first reported a position in Cassava Sciences, Inc. Warrant in Q1 2024 and held it in 1 quarter.
  • Barclays's Cassava Sciences, Inc. Warrant position peaked at $165K in Q1 2024.
  • 3 funds tracked by Wall St. Rank held Cassava Sciences, Inc. Warrant as of Q2 2024.

Based on Barclays's 13F filing for Q2 2024, filed 14 Aug 2024.